Project Title: Oligomer – Focused Screening and Individualized Therapeutics to target Neurodegenerative Disoders (OligoFIT)

Funding: JPND call for proposals: “Multinational research projects on Personalised Medicine for Neurodegenerative Diseases”

Project No.:  OligoFIT – PRL/20/9

Period: 36 months  01.04.2020.-31.03.2023.

Project funding: EUR 210 000.00

Partners: University of Oxford, University Medical Center Göttingen, University of Aarhus, Polytechnic School of Porto, University of Warsaw

Coordinator: Prof Martin Bachmann, University of Oxford

BMC Principle Investigator:  Dr. biol. K.Tārs

Project description:

The overall aim of OligoFIT is to detect pathological alpha-synuclein oligomer components with relevance to Lewi-body disease severity/status. Detected oligomers will be further used for development of biosensor-based diagnostics and therapeutic vaccine candidates.

BMC main task in this project is design, characterization and preclinical immunogenicity studies of therapeutic VLP-based vaccine candidate.

Information published: 01.04.2020.